Exploring JAK Inhibitors for Atopic Dermatitis
Not all JAKs are the same: Learn how JAKs can help your patients

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that significantly impacts quality of life for millions of patients. Recent advances in systemic therapies, including JAK inhibitors, offer new opportunities to address unmet needs in moderate-to-severe AD. Understanding the efficacy and safety profiles of these agents is essential for optimizing treatment strategies and improving patient outcomes.

Learn More